Oncology CRO Built for Sponsors,
Created By ExpertsTech-enabled CRO built to eliminate clinical trial pain points for faster execution and higher-quality trials.
Our Oncology CRO Executive Team
Our Oncology CRO team has over 150 years experience at leading CROs across modalities
Our experienced CRO executive team works closely with our expert site operations team to continuously review execution strategies, closely monitor patient recruitment efforts, and mitigate key study risks for Oncology clinical trials.
Medical Director, CRO
More than 20 years as a leading PI in Dermatology, has been the PI for 200+ Dermatology clinical trials across indications.
Why Choose Vial's Oncology CRO?
Streamlined oncology clinical trial startup, more predictable patient recruitment, and higher-quality data.
Vial leverages the expertise and abilities of our in-house oncologists and clinical delivery experts to offer oncology sponsors a CRO built for their greatest needs. Vial’s tech-enabled trial management system and seamless operating system ensure that trials are run with maximum efficiency.
We have thoughtfully built our scientific advisory board to include research experienced oncologists who not only have a passion for new oncology therapies, but also an understanding of how to harness the power of precision medicine and clinical data to combat the growing complexity of oncology clinical trials.
Site Network
Trials Powered by Vial’s
Fully Integrated Clinic Network
- Anne Truitt, MD Skin Surgery Medical Group San Diego, CA
- James Wang, MD Metropolis Dermatology Los Angeles, CA
- Pearl Grimes, MD Grimes Center For Medical and Aesthetic Dermatology Los Angeles, CA
- Forum Patel, MD Arya Dermatology San Francisco, CA
- Vipal Soni, MD Orange County Dermatology & Surgery Huntington Beach, CA
- Ronald Moy, MD Moy, Fincher, Chipps Dermatology Beverly Hills, CA
- Raja Sivamani, MD Integrative Skin Science and Research Sacramento, CA
- Adam Plotkin, MD Palm Beach Dermatology Delray Beach, FL
- Mark Nestor, MD, PHD Center for Clinical and Cosmetic Research Aventura, FL
- James Solomon, MD, PhD Ameriderm Research Ormond Beach, FL
- Mercedes Gonzalez, MD Pediatric Skin Research, LLC Coral Gables, FL
- David Fivenson, MD Fivenson Dermatology Ann Arbor, MI
- Steven Grekin, DO Grekin Skin Institute-Warren Warren, MI
- Steven Grekin, DO Grekin Skin Institute-Wyandotte Wyandotte, MI
- Steven Dayan, MD Denova Research Chicago, IL
- George Lewitt, MD Denova Research - IDI Chicago, IL
- Syed Ali, MD Acclaim Dermatology Sugar Land, TX
- Young Cho, MD Melissa Chiang, MD Integrated Aesthetics Spring, TX
- Melissa Chiang, MD Integrated Aesthetics Spring, TX
- Janet DuBois, MD DermResearch Austin, TX
- Richard Jackson, MD Yvonne Knight, MD Dominion Medical Associates Richmond, VA
- Yvonne Knight, MD Dominion Medical Associates Richmond, VA
- Vlada Groysman, MD Cahaba Dermatology Birmingham, AL
- Robert Haber, MD Haber Dermatology Beachwood, OH
- Mark Amster, MD MetroBoston Brighton, MA
- Robert Nossa, MD Contemporary Dermatology Marston Mills, MA
- David Goldberg, MD, JD Skin Laser & Surgery Specialists Hackensack, NJ
- Paul Lorenc, MD Lorenc Aesthetic Plastic Surgery New York city, NY
- Snehal Amin, MD MDCS Dermatology New York, NY
- Philip Werschler, MD Premier Clinical Research Spokane, WA
- Lawrence Green, MD Lawrence J. Green, MD LLC Rockville, MD
- Todd Schlesinger, MD Clinical Research Center of the Carolinas Charleston, SC
- Christina Correnti, MD DermASAP Quincy, MA
- Robert Snyder, MD Riverchase Dermatology (Pembroke Pines) Pembroke Pines, FL
- Dunnett Durando, DO Riverchase Dermatology (Fort Myers) Fort Myers, FL
- Michael Tolentino, MD Blue Ocean Clinical Research (Lakeland) Lakeland, FL
- Michael Tolentino, MD Blue Ocean Clinical Research (Lake Worth) Lake Worth, FL
- Wendy Roberts, MD Wendy Roberts MD Rancho Mirage, CA
- Sharleen St. Surin-Lord, MD Visage Dermatology Largo, MD
- Stephen Schleicher, MD DermDox Sugarloaf, PA
- Jonathan Weiss, MD Gwinnett Clinical Research Center, Inc. Snellville, GA
We have thoughtfully built our scientific advisory board to incorporate research experienced oncologists who not only have a passion for new oncology therapies, but also an understanding of how to harness the power of precision medicine and clinical data to combat the growing complexity of oncology clinical trials.
We have thoughtfully built our scientific advisory board to incorporate research experienced oncologists who not only have a passion for new oncology therapies, but also an understanding of how to harness the power of precision medicine and clinical data to combat the growing complexity of oncology clinical trials.
CRO Services
Supporting Clients With Innovative Services Provided by an Experienced Team
- Scientific Consultation
- Protocol Development
- Medical Writing
- Comprehensive Project Management
- Clinical Monitoring
- Medical Monitoring
- Data Management
- Biostatistics
- Pharmacovigilance
- Patient Recruiting
- Vial Patient Database
- Sites’ EMR Database
- Multi-Channel Marketing
- Experienced Call Center
Upon site activation, Vial’s recruitment engine goes to work, funneling patients in close geographic proximity to their site for screening and enrollment.
Accelerated Start-up
and Consolidated Site Activation
- Streamlined trial startup
- Centralized Reg Doc collection
- All sites activated within 30 days
- Single contractual agreement
Scientific Advisory Board
The Vial CRO is supported by a team of highly experienced Scientific Advisors. Our board members are leaders in the industry with real-life clinical trial expertise who provide insider knowledge, strategy, and direction to guide Vial's CRO for efficient oncology clinical trials.
Bladder Cancer Director at the Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School
Professor of Medicine and Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah
Professor of Medicine, Professor of Surgery, and Professor of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA)
The Vial Oncology CRO approach to harmonizing the power of precision medicine and its attack on cancer with data-driven patient recruitment solutions changes the game in oncology clinical trials.
— Name
Job title
Vial’s specialized oncology CRO expertise lies in running clinical trials with immune-oncology endpoints, matching molecular and clinical data to link the right patients to the right trials.
— Name
Title: Medical & Cosmetic Dermatology
Vial’s oncology CRO works across solid tumor and hematologic cancer trials, and deploys an operational process that results in highly efficient operations and site startup in less than 90 days.
— Name
Title: Medical & Cosmetic Dermatology
Case Study
Meeting Recruitment Timelines, Every Time.
Guaranteed.
In a Phase 3 SCLC trial,
all 3 Vial sites significantly beat the enrollment goals in a reduced time frame.
Our recruitment timelines are so predictably fast, we boldly stand by our guarantees.
In a Phase 3 Hyperhidrosis study,
all 3 Vial sites significantly beat the enrollment goals in a reduced time frame.
Our recruitment timelines are so predictably fast, we stand by our guarantees.
Deep clinic operation integration drives higher quality data for Sponsors.
Vial’s Oncology CRO is powered by a robust all-inclusive technology platform. Learn more about our innovative technology and experienced services to run your Oncology clinical trial more efficiently.
Learn more about the Vial’s tech-enabled platform.
5 Powerful Technology Solutions.
One Connected System.
eSource
Finally, paper is out, and digital is in.
EDC
Speed and efficiency that sponsors love.
eTMF
Seamless file management.
ePRO
Customizable for patients in your trial.
CTMS
Level up your trial trial operation.
Upcoming Events
Vial will be at Cell & Gene Meeting on the Mesa
Past Events
Webinar: Tech-Enabled Oncology Clinical Trials — Delivering Faster, Higher Quality Trials for Sponsors
Vial will be at the Clinical Operations in Oncology Trials East Coast 2022
Vial will be at the ASCO 2022 Annual Meeting
Tech-Enabled Remote Monitoring Part 1
Download our white paper to learn more about each stakeholder’s benefits of tech-enabled trials.
Tech-Enabled Remote Monitoring Part 2
Download our white paper to learn more about each stakeholder’s benefits of tech-enabled trials.
Vial’s Deployment of Modern, Intuitive Electronic Source
Download our latest white paper to learn how utilizing eSource in clinical trials can streamline process, increase efficiency, and minimize errors.
Indications
Broad Experience Across Oncology Indications and Phases
- Acute myeloid leukemia (AML)
- Bone marrow transplant
- Breast cancer
- Carcinoma in situ (CIS) bladder cancer
- Cervical cancer
- Chronic lymphocytic leukemia (CLL)
- Chronic myelogenous (or myeloid) leukemia (CML)
- Colorectal cancer
- Endometrial
- Gastrointestinal stromal tumor (GIST)
- Gliomas
- Head and neck cancer
- Hepatocellular carcinoma
- Idiopathic thrombocytopenic purpura (ITP)
- Lymphoma
- Malignant ascites
- Melanoma
- Multiple myeloma
- Myelodysplastic syndrome (MDS)
- Neuroendocrine
- Lung cancer
- oGVHD
- Ovarian cancer
- Pancreatic cancer
- Pediatric cancers
- Prostate cancer
- Renal cell carcinoma
- Sarcoma
Lightning Fast Start-up and Consolidated Site Activation
- Streamlined trial startup
- Centralized Reg Doc collection
- All sites activated within 30 days
- Single contractual agreement
Standardized Quality Across Our PIs
- Reviews and training on clinical assessments and grading scales EASI, PASI, etc.
- All Vial PIs trained on best practices bi-monthly
Highly Experienced CRCs
- Avg 4 years experience
- Beating Industry Retention
- Site Clinical Research Managers maintain best practices
